참고문헌 (14)

1. Centers for Disease ControlPrevention. 2013 National diabetes prevention Centers for Disease Control and Prevention. National diabetes prevention. Available from: http://www.cdc.gov/diabetes/prevention/prediabetes.html . Accessed Sep. 15, 2013. 

2. World Health Organization. 2013 Diabetes World Health Organization. Diabetes. Available from: http://who.int/mediacentre/factsheets/fs312/en/index.html . Accessed Apr. 20, 2013. 

3. American Diabetes Association. 2013 Diagnosing diabetes and learning about prediabetes American Diabetes Association. Diagnosing diabetes and learning about prediabetes. Available from: http://www.diabetes.org/diabetesbasics/diagnosis/?loc=DropDownDB-diagnosis. Accessed Apr. 2013. 

4. J. Nutr. Y Maeda 134 945 2004 10.1093/jn/134.4.945 Maeda Y, Kimura Y. Antitumor effects of various low-molecularweight chitosans are due to increased natural killer activity of intestinal intraepithelial lymphocytes in sarcoma 180-bearing mice. J. Nutr. 134: 945-950 (2004) 

   상세보기

5. Am. J. Physiol- Endoc. M. G Jiang 284 E671 2003 Jiang G, Zhang BB. Glucagon and regulation of glucose metabolism. Am. J. Physiol- Endoc. M. 284: E671-E678 (2003) 

6. J. Med. GT Ko 32 53 2001 Ko GT, Cockram CS, Chan JC. How to minimize missing those subjects with high 2HR plasma glucose but ‘normaľ fasting plasma glucose levels? J. Med. 32: 53-65 (2001) 

7. Diabetes Res. Clin. Pract. RR Holman 40 1 S21 1998 10.1016/S0168-8227(98)00038-2 Holman RR. Assessing the potential for α-glucosidase inhibitors in prediabetic states. Diabetes Res. Clin. Pract. 40 (Suppl. 1): S21-S25 (1998) 

   상세보기

8. Diabetes Care L Monnier 26 881 2003 10.2337/diacare.26.3.881 Monnier L, Lapinski H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: Variations with increasing levels of HbA1c. Diabetes Care 26: 881-885 (2003) 

   상세보기

9. Food Hydrocolloid. W Xia 25 170 2011 10.1016/j.foodhyd.2010.03.003 Xia W, Liu P, Zhang J, Chen J. Biological activities of chitosan and chitooligosaccharides. Food Hydrocolloid. 25: 170-179 (2011) 

   상세보기

10. Int. J. Biol. Macromole. C Qin 31 111 2002 10.1016/S0141-8130(02)00064-8 Qin C, Du Y, Xiao L, Li Z, Gao X. Enzymic preparation of watersoluble chitosan and their antitumor activity. Int. J. Biol. Macromole. 31: 111-117 (2002) 

    상세보기

11. Carbohyd. Polym. SK Kim 62 357 2005 10.1016/j.carbpol.2005.08.012 Kim SK, Rajapakse N. Enzymatic production and biological activities of chitosan oligosaccharides (COS): A review. Carbohyd. Polym. 62: 357-368 (2005) 

    상세보기

12. Proteomics SG Kumar 9 2149 2009 10.1002/pmic.200800571 Kumar SG, Rahman MA, Lee SH, Hwang HS, Kim HA, Yun JW. Plasma proteome analysis for anti-obesity and anti-diabetic potentials of chitosan oligosaccharides in ob/ob mice. Proteomics 9: 2149-2162 (2009) 

    상세보기

13. Biol. Pharmaceut. Bull. Y Kondo 23 1458 2000 10.1248/bpb.23.1458 Kondo Y, Nakatani A, Hayashi K, Ito M. Low molecular weight chitosan prevents the progression of low dose streptozotocininduced slowly progressive diabetes mellitus in mice. Biol. Pharmaceut. Bull. 23: 1458-1464 (2000) 

    상세보기

14. Int. J. Mol. Sci. SH Jo 14 14214 2013 10.3390/ijms140714214 Jo SH, Ha KS, Moon KS, Kim JG, Oh CG, Kim YC, Apostolidis E, Kwon YI. Molecular weight dependent glucose lowering effect of low molecular weight chitosan oligosaccharide (GO2KA1) on postprandial blood glucose level in SD rats model. Int. J. Mol. Sci. 14: 14214-14224 (2013) 

    상세보기